| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/03/2003 | WO2003000889A2 Identification of ses-1 and the uses of the same |
| 01/03/2003 | WO2003000864A2 Nucleic acid-associated proteins |
| 01/03/2003 | WO2003000859A2 G-protein coupled receptors |
| 01/03/2003 | WO2003000846A2 A novel g protein-coupled receptor, gave 3 |
| 01/03/2003 | WO2003000844A2 Protein modification and maintenance molecules |
| 01/03/2003 | WO2003000842A2 Novel proteins and nucleic acids encoding same |
| 01/03/2003 | WO2003000840A2 Nitrilases |
| 01/03/2003 | WO2003000737A2 MOUSE μ LIGHT CHAIN LOCUS |
| 01/03/2003 | WO2003000736A1 Humanized antibodies derived from dd-3b6/22, specific for the d-dimer fragment of fibrin |
| 01/03/2003 | WO2003000730A1 Compounds that modulate estrogen actions |
| 01/03/2003 | WO2003000729A2 Secreted polypeptide and their use in the treatment of bone disorders |
| 01/03/2003 | WO2003000727A2 Atopy |
| 01/03/2003 | WO2003000722A1 Multi-copper oxidase protein enzymes for iron(ii) acquisition in prokaryotic cells |
| 01/03/2003 | WO2003000721A2 Mycobacterial antigens expressed under low oxygen tension |
| 01/03/2003 | WO2003000717A2 Identification of ses-3 (spr-5) in c. elegans and the uses of the same |
| 01/03/2003 | WO2003000714A2 Compositions and methods for preventing protein aggregation in neurodegenerative diseases |
| 01/03/2003 | WO2003000286A1 Remedies for eosinophilic diseases |
| 01/03/2003 | WO2003000271A2 System and method for the large scale labeling of compounds with radiohalogens |
| 01/03/2003 | WO2003000199A2 Ilt3 and ilt4-related compositions and methods |
| 01/03/2003 | WO2003000183A2 Method of treating atherosclerosis and other inflammatory diseases |
| 01/03/2003 | WO2003000176A2 Conjugates of reduced antibodies and biomolecules |
| 01/03/2003 | WO2003000117A2 Detection and treatment of prostate cancer |
| 01/03/2003 | WO2003000113A2 Compositions and methods for the diagnosis and treatment of tumor |
| 01/03/2003 | WO2003000024A2 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection |
| 01/03/2003 | WO2003000021A2 Pancam nucleic acids and polypeptides |
| 01/03/2003 | WO2003000014A2 Spherical protein particles and methods of making and using them |
| 01/03/2003 | WO2002081661A3 Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides |
| 01/03/2003 | WO2002060919A9 Molecules with extended half-lives, compositions and uses thereof |
| 01/03/2003 | WO2002055725A9 Novel nucleic acids, methods and transformed cells for the modulation of gibberellin production |
| 01/03/2003 | WO2002045653A3 Combination radiation therapy and chemotherapy in conjuction with administration of growth factor receptor antibody |
| 01/03/2003 | WO2002032375A9 Uses of monoclonal antibody 8h9 |
| 01/03/2003 | WO2002028891A3 Listeria inocua, genome and applications |
| 01/03/2003 | WO2002024748A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 01/03/2003 | WO2002020764A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 01/03/2003 | WO2002020620A3 Monoclonal antibody against ovarian carcinoma |
| 01/03/2003 | WO2002020562A3 Family member of inhibitor of apoptosis proteins |
| 01/03/2003 | WO2002018536A3 Truncated bard1 protein, and its diagnostic and therapeutic uses |
| 01/03/2003 | WO2002016429A3 Compositions and methods for the diagnosis and treatment of tumor |
| 01/03/2003 | WO2002012501A3 Anti-dual integrin antibodies, compositions, methods and uses |
| 01/03/2003 | WO2002012500A3 Anti-il-12 antibodies, compositions, methods and uses |
| 01/03/2003 | WO2002010387A3 G-protein coupled receptors |
| 01/03/2003 | WO2002004611A3 Aminoacyl trna synthetases |
| 01/03/2003 | WO2002002757A3 Adenylyl and guanylyl cyclases |
| 01/03/2003 | WO2002002627A3 Interferon-like protein zcyto21 |
| 01/03/2003 | WO2002002603A3 Protein modification and maintenance molecules |
| 01/03/2003 | WO2002002131A3 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 01/03/2003 | WO2002000728A3 Methods and compositions for isolating biologically active antibodies |
| 01/03/2003 | WO2002000727A3 Gp286 nucleic acids and polypeptides |
| 01/03/2003 | WO2002000724A3 Thymic stromal lymphopoietin receptor molecules and uses thereof |
| 01/03/2003 | WO2001098470A3 Recombinant proteolytic tryptases, active site mutants thereof, and methods of making same |
| 01/03/2003 | WO2001098468A3 Proteases |
| 01/03/2003 | WO2001098357A3 Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations |
| 01/03/2003 | WO2001092528A3 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 01/03/2003 | WO2001081581A9 Compositions and methods for the therapy and diagnosis of acne vulgaris |
| 01/03/2003 | CA2677781A1 Nitrilases |
| 01/03/2003 | CA2633595A1 Antibodies against tumor-associated antigenic target (tat) polypeptides |
| 01/03/2003 | CA2489623A1 Atopy |
| 01/03/2003 | CA2459985A1 Pancam nucleic acids and polypeptides |
| 01/03/2003 | CA2452049A1 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection |
| 01/03/2003 | CA2451686A1 A novel g protein-coupled receptor, gave 3 |
| 01/03/2003 | CA2451493A1 Cell growth inhibitors containing anti-glypican 3 antibody |
| 01/03/2003 | CA2451351A1 A method for diagnosing a person having multiple sclerosis |
| 01/03/2003 | CA2451271A1 Pancam nucleic acids and polypeptides |
| 01/03/2003 | CA2451239A1 Antibodies against tumor-associated antigenic taget (tat) polypeptides |
| 01/03/2003 | CA2451185A1 Spherical protein particles and methods of making and using them |
| 01/03/2003 | CA2451138A1 Remedies for eosinophilic diseases |
| 01/03/2003 | CA2451026A1 Mycobacterial antigens expressed under low oxygen tension |
| 01/03/2003 | CA2450969A1 Nucleic acid-associated proteins |
| 01/03/2003 | CA2450954A1 Method of treating atherosclerosis and other inflammatory diseases |
| 01/03/2003 | CA2450925A1 G-protein coupled receptors |
| 01/03/2003 | CA2450921A1 Protein modification and maintenance molecules |
| 01/03/2003 | CA2450828A1 Humanized antibodies derived from dd-3b6/22, specific for the d-dimer fragment of fibrin |
| 01/02/2003 | US20030004710 Short-term enhancement in celp speech coding |
| 01/02/2003 | US20030004324 31 human secreted proteins |
| 01/02/2003 | US20030004318 Anticancer agents |
| 01/02/2003 | US20030004317 Nucleic acids encoding anti-human alphanubeta3 and alphanubeta5 antibodies |
| 01/02/2003 | US20030004310 Culture product |
| 01/02/2003 | US20030004210 Coupling to cell binding agent; killing cells |
| 01/02/2003 | US20030004123 Targeted gene transfer using G protein coupled receptors |
| 01/02/2003 | US20030004114 Method of inhibiting fungal growth |
| 01/02/2003 | US20030004106 Interleukin-1 receptor antagonist-related molecules and uses thereof |
| 01/02/2003 | US20030004102 Genetic engineering; immunosuppressants, anticancer agents |
| 01/02/2003 | US20030004097 Methods and compositions for inducing autoimmunity in the treatment of cancers |
| 01/02/2003 | US20030004092 Methods and agents for inducing apoptosis and methods for their identification |
| 01/02/2003 | US20030003597 Diagnosing pregnancy in humans; obtain sample, incubate with antibody, monitor complex formation, presence of complex indicates pregnancy |
| 01/02/2003 | US20030003555 Nucleotide sequences coding proteins for use in the diagnosis and treatment of hematopoietic or immune disorders |
| 01/02/2003 | US20030003545 Nucleotide sequences coding polypeptide for use in the treatment of immunological defects |
| 01/02/2003 | US20030003542 ACPL polypeptides |
| 01/02/2003 | US20030003541 Nucleotide sequences coding peptide for use in the treatment of skin, brain and eye disorders |
| 01/02/2003 | US20030003532 Novel nucleic acid sequences encoding human slit-, megf-, and roundabout-like polypeptides |
| 01/02/2003 | US20030003531 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/02/2003 | US20030003530 Nucleotide sequences coding protein for use in diagnosis and treatment of skin and cancer disorders |
| 01/02/2003 | US20030003518 Nuclear envelope protein recognized by atypical p-ANCA in patients with inflammatory bowel disease and autoimmune liver diseases |
| 01/02/2003 | US20030003515 Diagnosing cardiovascular disorders; obtain sample, determine fibrinogen concentrations, compare to control, amplified concentration of fibrinogin indicates cardiovascular disorders |
| 01/02/2003 | US20030003508 Serological diagnostic method with rickettsia pulicis bacterium |
| 01/02/2003 | US20030003507 Compositions and methods for the diagnosis and treatment of tumor |
| 01/02/2003 | US20030003502 Three-dimensional model of a complex between a Fc epsilon receptor alpha chain and a Fc region of an IgE antibody and uses thereof |
| 01/02/2003 | US20030003477 Nucleotide sequences coding polypeptides for use in the treatment of nervous system, kidney, muscle, allergic and cancer disorders |
| 01/02/2003 | US20030003462 Novel human interleukin-like proteins and polynucleotides encoding them |
| 01/02/2003 | US20030003447 Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus |